CRCA vs. ACLO
CRCA (ProShares Ultra CRCL) and ACLO (TCW AAA CLO ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while ACLO is a CLO fund actively managed by TCW. Both are actively managed. At a correlation of -0.03, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.20%/yr for ACLO.
Performance
CRCA vs. ACLO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -25.37% return, which is significantly lower than ACLO's 2.21% return.
CRCA
- 1D
- -20.86%
- 1M
- -48.25%
- YTD
- -25.37%
- 6M
- -39.99%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ACLO
- 1D
- 0.02%
- 1M
- 0.42%
- YTD
- 2.21%
- 6M
- 2.58%
- 1Y
- 5.31%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRCA vs. ACLO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -25.37% | -81.81% |
ACLO TCW AAA CLO ETF | 2.21% | 1.98% |
Correlation
The correlation between CRCA and ACLO is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025 | -0.03 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. ACLO — Risk / Return Rank
CRCA
ACLO
CRCA vs. ACLO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and TCW AAA CLO ETF (ACLO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CRCA | ACLO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 7.29 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.47 | 5.10 | -5.57 |
Drawdowns
CRCA vs. ACLO - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.02%, which is greater than ACLO's maximum drawdown of -1.01%. Use the drawdown chart below to compare losses from any high point for CRCA and ACLO.
Loading charts...
Drawdown Indicators
| CRCA | ACLO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.02% | -1.01% | -93.01% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.27% | — |
Current DrawdownCurrent decline from peak | -87.98% | 0.00% | -87.98% |
Average DrawdownAverage peak-to-trough decline | -69.26% | -0.05% | -69.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.03% | — |
Volatility
CRCA vs. ACLO - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | ACLO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.14% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.57% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 196.79% | 0.73% | +196.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 196.79% | 1.08% | +195.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 196.79% | 1.08% | +195.71% |
CRCA vs. ACLO - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than ACLO's 0.20% expense ratio.
Dividends
CRCA vs. ACLO - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 2.32%, less than ACLO's 4.91% yield.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
ACLO TCW AAA CLO ETF | 4.91% | 4.87% | 0.59% |
CRCA ProShares Ultra CRCL | 2.32% | 1.06% | 0.00% |
Frequently Asked Questions
CRCA and ACLO have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, ACLO is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.
ACLO is cheaper with a 0.20% expense ratio, compared with 0.95% for CRCA.
ACLO has the higher dividend yield at 4.91%, compared with 2.32% for CRCA.
CRCA is categorized as Leveraged Equities, while ACLO is CLO. They also come from different issuers: ProShares and TCW. Their fees differ too: 0.95% for CRCA and 0.20% for ACLO.
Find the right allocation for CRCA and ACLO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer